229 related articles for article (PubMed ID: 27052656)
1. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
[TBL] [Abstract][Full Text] [Related]
2. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
4. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
[TBL] [Abstract][Full Text] [Related]
5. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
[TBL] [Abstract][Full Text] [Related]
7. Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinoma.
Patel H; Polanco-Echeverry G; Segditsas S; Volikos E; McCart A; Lai C; Guenther T; Zaitoun A; Sieber O; Ilyas M; Northover J; Silver A
Int J Cancer; 2007 Dec; 121(12):2668-73. PubMed ID: 17721920
[TBL] [Abstract][Full Text] [Related]
8. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
[TBL] [Abstract][Full Text] [Related]
10. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
[TBL] [Abstract][Full Text] [Related]
12. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
[TBL] [Abstract][Full Text] [Related]
14. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
Lu DW; El-Mofty SK; Wang HL
Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of high-risk human papillomavirus DNA and p16
Obermueller T; Hautekiet J; Busto MP; Reynders D; Belgioia L; Cats A; Gilbert DC; Koerber SA; Mai S; Meulendijks D; Rödel F; Yhim HY; Hetjens S; Weiß C; Rasmussen CL; Urbute A; Verdoodt F; Kjaer SK; Reuschenbach M; Goetghebeur E; von Knebel Doeberitz M; Arbyn M; Prigge ES
Eur J Cancer; 2021 Nov; 157():165-178. PubMed ID: 34517306
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
17. Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
Ramberg I; Vieira FG; Toft PB; von Buchwald C; Funding M; Nielsen FC; Heegaard S
Invest Ophthalmol Vis Sci; 2021 Nov; 62(14):11. PubMed ID: 34779821
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis.
Baricevic I; He X; Chakrabarty B; Oliver AW; Bailey C; Summers J; Hampson L; Hampson I; Gilbert DC; Renehan AG
Eur J Cancer; 2015 Apr; 51(6):776-85. PubMed ID: 25702585
[TBL] [Abstract][Full Text] [Related]
19. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
[No Abstract] [Full Text] [Related]
20. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma.
Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A
J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
